Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study.

Allemani C, Rachet B, Weir HK, Richardson LC, Lepage C, Faivre J, Gatta G, Capocaccia R, Sant M, Baili P, Lombardo C, Aareleid T, Ardanaz E, Bielska-Lasota M, Bolick S, Cress R, Elferink M, Fulton JP, Galceran J, Gózdz S, Hakulinen T, Primic-Zakelj M, Rachtan J, Diba CS, Sánchez MJ, Schymura MJ, Shen T, Tagliabue G, Tumino R, Vercelli M, Wolf HJ, Wu XC, Coleman MP.

BMJ Open. 2013 Sep 10;3(9):e003055. doi: 10.1136/bmjopen-2013-003055. Erratum in: BMJ Open. 2013;3(10):e003055corr1.

2.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
3.

Breast cancer survival in the US and Europe: a CONCORD high-resolution study.

Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, Siesling S, Torrella-Ramos A, Voogd AC, Aareleid T, Ardanaz E, Berrino F, Bielska-Lasota M, Bolick S, Cirilli C, Colonna M, Contiero P, Cress R, Crocetti E, Fulton JP, Grosclaude P, Hakulinen T, Izarzugaza MI, Malmström P, Peignaux K, Primic-Žakelj M, Rachtan J, Safaei Diba C, Sánchez MJ, Schymura MJ, Shen T, Traina A, Tryggvadottir L, Tumino R, Velten M, Vercelli M, Wolf HJ, Woronoff AS, Wu X, Coleman MP.

Int J Cancer. 2013 Mar 1;132(5):1170-81. doi: 10.1002/ijc.27725. Epub 2012 Sep 18.

4.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

5.

Postoperative adjuvant chemotherapy in rectal cancer operated for cure.

Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD004078. doi: 10.1002/14651858.CD004078.pub2. Review.

PMID:
22419291
6.

Site and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial.

Pugh SA, Shinkins B, Fuller A, Mellor J, Mant D, Primrose JN.

Ann Surg. 2016 Jun;263(6):1143-7. doi: 10.1097/SLA.0000000000001351.

PMID:
26135689
7.

Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology.

Gatta G, Ciccolallo L, Capocaccia R, Coleman MP, Hakulinen T, Møller H, Berrino F; EUROCARE Working Group.

Eur J Cancer. 2003 Oct;39(15):2214-22.

PMID:
14522381
8.

Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.

Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.

Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.

PMID:
11326694
9.

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M.

J Clin Oncol. 2011 Apr 20;29(12):1547-55. doi: 10.1200/JCO.2010.30.5151. Epub 2011 Mar 21.

PMID:
21422427
10.

Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.

Mukai M, Ito I, Mukoyama S, Tajima T, Saito Y, Nakasaki H, Sato S, Makuuchi H.

Oncol Rep. 2003 Jul-Aug;10(4):927-34.

PMID:
12792747
11.

Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.

De Quay N, Cerottini JP, Albe X, Saraga E, Givel JC, Caplin S.

Eur J Surg. 1999 Jun;165(6):588-92.

PMID:
10433145
12.

Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.

Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Pahl H, Fateh-Moghadam A.

Anticancer Res. 1997 Jul-Aug;17(4B):2935-8.

PMID:
9329568
13.

Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis.

Bentzen SM, Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Sørensen F, Bone J, Jacobsen NO, Sell A, Overgaard J, Bertelsen K, et al.

Br J Cancer. 1992 Jan;65(1):102-7.

14.

Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.

Kune GA, Kune S, Field B, White R, Brough W, Schellenberger R, Watson LF.

Dis Colon Rectum. 1990 Nov;33(11):938-46.

PMID:
2226081
15.

For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.

Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC.

Cancer. 1998 Aug 15;83(4):666-72.

PMID:
9708929
16.

Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.

Sheehan KM, O'Donovan DG, Fitzmaurice G, O'Grady A, O'Donoghue DP, Sheahan K, Byrne MF, Conroy RM, Kay EW, Murray FE.

Eur J Gastroenterol Hepatol. 2003 Apr;15(4):375-80.

PMID:
12655257
17.

Cancer survival in five continents: a worldwide population-based study (CONCORD).

Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL; CONCORD Working Group.

Lancet Oncol. 2008 Aug;9(8):730-56. doi: 10.1016/S1470-2045(08)70179-7. Epub 2008 Jul 17.

18.

Survival of patients with colorectal cancer detected by a community screening program.

Rae LC, Gibberd RW.

Med J Aust. 2000 Jan 3;172(1):13-5.

PMID:
10682009
19.

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I; EUROCARE-4 Working Group.

Lancet Oncol. 2007 Sep;8(9):784-96. Erratum in: Lancet Oncol. 2008 May;9(5):416.

PMID:
17714993
20.

Rectal cancer in the Kingdom of Saudi Arabia: the King Faisal Specialist Hospital experience.

Isbister WH, Murad M, Habib Z.

Aust N Z J Surg. 2000 Apr;70(4):269-74.

PMID:
10779058

Supplemental Content

Support Center